Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(One intermediate revision by the same user not shown)
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (PITUITARY TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mammosomatotroph_PitNET/adenoma|Mammosomatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Lactotroph_PitNET/adenoma|Lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Thyrotroph_PitNET/adenoma|Thyrotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mature_plurihormonal_PIT1-lineage_PitNET/adenoma|Mature plurihormonal PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 92:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Immature_PIT1-lineage_PitNET/adenoma|Immature PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 103:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Acidophil_stem_cell_PitNET/adenoma|Acidophil stem cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 114:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_somatotroph-lactotroph_PitNET/adenoma|Mixed somatotroph-lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 125:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Corticotroph_PitNET/adenoma|Corticotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 136:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gonadotroph_PitNET/adenoma|Gonadotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 147:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Null_cell_PitNET/adenoma|Null cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 158:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Plurihormonal_PitNET/adenomas|Plurihormonal PitNET/adenomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 169:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Multiple_synchronous_PitNET/adenomas_of_distinct_lineages|Multiple synchronous PitNET/adenomas of distinct lineages]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 180:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Metastatic_PitNET|Metastatic PitNET]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 191:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 202:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 213:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 224:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituicytomas|Pituicytomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 235:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gangliocytoma_and_mixed_gangliocytoma-PitNET/adenoma|Gangliocytoma and mixed gangliocytoma-PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Sellar_neurocytoma|Sellar neurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Meningiomas|Meningiomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 268:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 279:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 3 (THYROID TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 310:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Other_congenital_thyroid_abnormalities|Other congenital thyroid abnormalities]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 321:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_follicular_nodular_disease|Thyroid follicular nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 332:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma|Follicular thyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 343:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma_with_papillary_architecture|Follicular thyroid adenoma with papillary architecture]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 354:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_adenoma_of_the_thyroid|Oncocytic adenoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 365:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-invasive_follicular_thyroid_neoplasm_with_papillary-like_nuclear_features|Non-invasive follicular thyroid neoplasm with papillary-like nuclear features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 376:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_tumours_of_uncertain_malignant_potential|Thyroid tumours of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 387:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Hyalinizing_trabecular_tumour|Hyalinizing trabecular tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 398:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_carcinoma|Follicular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 409:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Invasive_encapsulated_follicular_variant_of_papillary_thyroid_carcinoma|Invasive encapsulated follicular variant of papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 420:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 431:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_carcinoma_of_the_thyroid|Oncocytic carcinoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 442:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:High-grade_follicular_cell-derived_non-anaplastic_thyroid_carcinoma|High-grade follicular cell-derived non-anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 453:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Anaplastic_thyroid_carcinoma|Anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 464:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 475:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_medullary_and_follicular_cell-derived_thyroid_carcinomas|Mixed medullary and follicular cell-derived thyroid carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 486:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 497:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 508:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sclerosing_mucoepidermoid_carcinoma_with_eosinophilia|Sclerosing mucoepidermoid carcinoma with eosinophilia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 519:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Cribriform_morular_thyroid_carcinoma|Cribriform morular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 530:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thymoma|Thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 541:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 552:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Intrathyroidal_thymic_carcinoma|Intrathyroidal thymic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 563:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroblastoma|Thyroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 574:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 4 (PARATHYROID TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 605:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_adenoma|Parathyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 616:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_lipoadenoma|Parathyroid lipoadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 627:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Atypical_parathyroid_tumour|Atypical parathyroid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 638:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_carcinoma|Parathyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 649:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 5 (ADRENAL GLAND TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_rests|Adrenal rests]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 680:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cysts|Adrenal cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 691:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_myelolipoma|Adrenal myelolipoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 702:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Congenital_adrenal_hyperplasia|Congenital adrenal hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 713:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenocortical_nodular_disease|Adrenocortical nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 724:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_adenoma|Adrenal cortical adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 735:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_carcinoma|Adrenal cortical carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 746:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_sex_cord_stromal_tumour|Adrenal sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 757:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adenomatoid_tumour|Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 768:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_melanoma|Adrenal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 779:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 810:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 821:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_nodular|Ganglioneuroblastoma, nodular]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 832:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroma|Ganglioneuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 843:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Phaeochromocytoma|Phaeochromocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 854:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 865:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parasympathetic_paraganglioma|Parasympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 876:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Composite_phaeochromocytomas_and_paragangliomas|Composite phaeochromocytomas and paragangliomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 887:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 918:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Insulinoma|Insulinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 929:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Glucagonoma|Glucagonoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 940:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Somatostatinoma|Somatostatinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 951:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gastrinoma|Gastrinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 962:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:VIPoma|VIPoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 973:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Serotonin-producing_tumours_with_and_without_carcinoid_syndrome|Serotonin-producing tumours with and without carcinoid syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 984:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Other_pancreatic_neuroendocrine_tumours_with_ectopic_hormone_production|Other pancreatic neuroendocrine tumours with ectopic hormone production]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 995:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,006:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_ductal_adenocarcinoma-neuroendocrine_neoplasms|Mixed ductal adenocarcinoma-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,017:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_acinar-neuroendocrine_carcinoma|Mixed acinar-neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,028:
 
|
 
|
 
|-
 
|-
 +
|CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS)
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mixed_neuroendocrine-non-neuroendocrine_neoplasms|Mixed neuroendocrine-non-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Composite_gangliocytoma/neuroma_and_neuroendocrine_tumour|Composite gangliocytoma/neuroma and neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Benign_vascular_tumours|Benign vascular tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glomangioma_and_glomus_tumour|Glomangioma and glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (GERM CELL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (METASTASIS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:MAFA-related_familial_insulinomatosis|MAFA-related familial insulinomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Syndromic_familial_follicular_cell-derived_thyroid_tumours|Syndromic familial follicular cell-derived thyroid tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Non-syndromic_familial_follicular_cell-derived_thyroid_tumours|Non-syndromic familial follicular cell-derived thyroid tumours]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 11:21, 26 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (PITUITARY TUMOURS)
Somatotroph PitNET/adenoma Disease
Mammosomatotroph PitNET/adenoma Disease
Lactotroph PitNET/adenoma Disease
Thyrotroph PitNET/adenoma Disease
Mature plurihormonal PIT1-lineage PitNET/adenoma Disease
Immature PIT1-lineage PitNET/adenoma Disease
Acidophil stem cell PitNET/adenoma Disease
Mixed somatotroph-lactotroph PitNET/adenoma Disease
Corticotroph PitNET/adenoma Disease
Gonadotroph PitNET/adenoma Disease
Null cell PitNET/adenoma Disease
Plurihormonal PitNET/adenomas Disease
Multiple synchronous PitNET/adenomas of distinct lineages Disease
Metastatic PitNET Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituitary blastoma Disease
Pituicytomas Disease
Gangliocytoma and mixed gangliocytoma-PitNET/adenoma Disease
Sellar neurocytoma Disease
Meningiomas Disease
Chordoma Disease
CHAPTER 3 (THYROID TUMOURS)
Thyroglossal duct cyst Disease
Other congenital thyroid abnormalities Disease
Thyroid follicular nodular disease Disease
Follicular thyroid adenoma Disease
Follicular thyroid adenoma with papillary architecture Disease
Oncocytic adenoma of the thyroid Disease
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features Disease
Thyroid tumours of uncertain malignant potential Disease
Hyalinizing trabecular tumour Disease
Follicular thyroid carcinoma Disease
Invasive encapsulated follicular variant of papillary thyroid carcinoma Disease
Papillary thyroid carcinoma Disease
Oncocytic carcinoma of the thyroid Disease
High-grade follicular cell-derived non-anaplastic thyroid carcinoma Disease
Anaplastic thyroid carcinoma Disease
Medullary thyroid carcinoma Disease
Mixed medullary and follicular cell-derived thyroid carcinomas Disease
Mucoepidermoid carcinoma Disease
Secretory carcinoma Disease
Sclerosing mucoepidermoid carcinoma with eosinophilia Disease
Cribriform morular thyroid carcinoma Disease
Thymoma Disease
Spindle epithelial tumour with thymus-like elements Disease
Intrathyroidal thymic carcinoma Disease
Thyroblastoma Disease
CHAPTER 4 (PARATHYROID TUMOURS)
Parathyroid hyperplasia Disease
Parathyroid adenoma Disease
Parathyroid lipoadenoma Disease
Atypical parathyroid tumour Disease
Parathyroid carcinoma Disease
CHAPTER 5 (ADRENAL GLAND TUMOURS)
Adrenal rests Disease
Adrenal cysts Disease
Adrenal myelolipoma Disease
Congenital adrenal hyperplasia Disease
Adrenocortical nodular disease Disease
Adrenal cortical adenoma Disease
Adrenal cortical carcinoma Disease
Adrenal sex cord stromal tumour Disease
Adenomatoid tumour Disease
Adrenal melanoma Disease
CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS)
Neuroblastoma Disease
Ganglioneuroblastoma, intermixed Disease
Ganglioneuroblastoma, nodular Disease
Ganglioneuroma Disease
Phaeochromocytoma Disease
Sympathetic paraganglioma Disease
Parasympathetic paraganglioma Disease
Composite phaeochromocytomas and paragangliomas Disease
CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS)
Non-functioning (non-syndromic) pancreatic neuroendocrine tumours Disease
Insulinoma Disease
Glucagonoma Disease
Somatostatinoma Disease
Gastrinoma Disease
VIPoma Disease
Serotonin-producing tumours with and without carcinoid syndrome Disease
Other pancreatic neuroendocrine tumours with ectopic hormone production Disease
Pancreatic neuroendocrine carcinoma Disease
Mixed ductal adenocarcinoma-neuroendocrine neoplasms Disease
Mixed acinar-neuroendocrine carcinoma Disease
CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS)
Neuroendocrine tumours Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Merkel cell carcinoma Disease
Mixed neuroendocrine-non-neuroendocrine neoplasms Disease
Composite gangliocytoma/neuroma and neuroendocrine tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS)
Lipoma Disease
Solitary fibrous tumour Disease
Benign vascular tumours Disease
PEComa Disease
Glomangioma and glomus tumour Disease
Angiosarcoma Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcomas Disease
Schwannoma Disease
Neurofibroma Disease
Granular cell tumour Disease
Malignant peripheral nerve sheath tumour Disease
CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
IgG4-related disease Disease
Extranodal marginal zone lymphoma Disease
Diffuse large B-cell lymphoma Disease
Langerhans cell histiocytosis Disease
Rosai-Dorfman disease Disease
Erdheim-Chester disease Disease
Follicular dendritic cell sarcoma Disease
CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours in endocrine organs Disease
Teratomas with endocrine differentiation Disease
CHAPTER 12 (METASTASIS)
Metastasis to the pituitary gland Disease
Metastasis to the thyroid gland Disease
Metastasis to the adrenal gland Disease
CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS)
Multiple endocrine neoplasia type 1 Disease
Multiple endocrine neoplasia type 2 Disease
Multiple endocrine neoplasia type 4 Disease
Multiple endocrine neoplasia type 5 (MAX-related tumours) Disease
Hyperparathyroidism-jaw tumour syndrome Disease
Von Hippel-Lindau syndrome Disease
SDH-deficient tumour syndromes Disease
Neurofibromatosis type 1 Disease
Carney complex Disease
McCune-Albright syndrome Disease
DICER1 syndrome Disease
Glucagon cell hyperplasia and neoplasia Disease
MAFA-related familial insulinomatosis Disease
Syndromic familial follicular cell-derived thyroid tumours Disease
Non-syndromic familial follicular cell-derived thyroid tumours Disease
Retrieved from "https://ccga.io/index.php?title=ENDO5:Volunteer_Assignments_and_Opportunities&oldid=14260"